Announcing a new article publication for Cardiovascular Innovations and Applications journal. Transglutaminase 2 (TGM2) has ...
Analysis of the FOURIER trial shows that evolocumab provides greater MACE risk reduction in patients with higher BMI and stable ASCVD.
Announcing a new article publication for Cardiovascular Innovations and Applications journal. Myocardial infarction (MI) triggers adverse remodeling mechanisms, thus leading to heart failure. Since ...
- Reduced inflammation at the site of myocardial infarction and improved heart function demonstrated. Novel therapy to modulate immune response with apoptotic cell-derived nanovesicles. Myocardial ...
Objective The aim of this study was to investigate the relationship between antineutrophil cytoplasmic antibodies (ANCA) ...
Find out more about how loss of Y chromosome in ageing males was linked to higher heart attack risk in a large prospective ...
Credit: Getty Images A discussion of the use of beta-blocker therapy following AMI, with Christopher Granger, MD, Gregg Fonarow, MD, and Carlin S Long, MD. Beta blockers have long been included in the ...
Patients recently diagnosed with cancer show an increased risk for major bleeding after myocardial infarction, with the risk ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback